1. Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada;
2. INSERM Unité Mixte de Recherche (UMR) S1052, Centre National de la Recherche UMR 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France;
3. Pathology Department, Necker Enfants Malades Hospital, Université Paris Descartes, Assistance Publique–Hôpitaux de Paris (AP–HP), Paris, France;
4. Pathology Department, Gustave Roussy, Université Paris-Saclay, INSERM U1170, Villejuif, France;
5. Pathology Department, Groupe Hospitalier Cochin, AP-HP, Paris, France;
6. INSERM U1138, Paris Descartes University-Sorbonne Paris Cité, Paris, France;
7. Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;
8. Département d’Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France;
9. Department of Hematology, François Mitterrand University Hospital, INSERM U1231, Dijon, France;
10. Institut Universitaire du Cancer-Oncopole de Toulouse, CHU Toulouse, INSERM U1037, Centre de Recherche en Cancerologie de Toulouse-Purpan, Toulouse-Purpan, France; and
11. Département de Pathologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France